Emil Kuriakose is a Primary Care physician. OpenAlex indexes 36 publications with 452 citations (h-index 9); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial
Sponsor: Calithera Biosciences, Inc
- Study to Evaluate the Safety of CB-280 in Patients With Cystic Fibrosis
Sponsor: Calithera Biosciences, Inc
- KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC
Sponsor: Calithera Biosciences, Inc
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Fei Wang, MD
Cornell University
Michael Hassman, DO
Barbara Rizzardi, MD
Kimball Johnson, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”